Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

WATSON LABS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 22
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 19
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 24
  • 0 comments

FDA approve PREGABALIN

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 17
  • 0 comments

FDA approve DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE

Comment Full text

VISTAPHARM

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 24
  • 0 comments

FDA approve METHADONE HYDROCHLORIDE

Comment Full text

ACTAVIS INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 19
  • 0 comments

FDA approve DOXORUBICIN HYDROCHLORIDE

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 18
  • 0 comments

FDA approve LITHIUM CARBONATE

Comment Full text

AMPHASTAR PHARM

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 22
  • 0 comments

FDA approve HYALURONIDASE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 18
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 20
  • 0 comments

FDA approve VORICONAZOLE

Comment Full text
  • Previous
  • 270
  • 271
  • 272
  • 273
  • 274
  • Next

Search

News categories

  • Technical Exchange News(9977)
  • Event(412)
  • SEC News(168796)
  • FDA Approval(9380)
  • Company Report(721)
  • Business News(112505)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin